BAYER AG TO ACQUIRE STERLING OTCs IN NORTH AMERICA FROM SMITHKLINE BEECHAM
This article was originally published in The Tan Sheet
Executive Summary
BAYER AG TO ACQUIRE STERLING OTCs IN NORTH AMERICA FROM SMITHKLINE BEECHAM for $1 bil. in a deal announced only two weeks after SmithKline cemented an agreement with Eastman Kodak to purchase Sterling Winthrop's global OTC business ("The Tan Sheet" Sept. 5, pp. 1-7). The acquisition of Sterling's North American OTC business, announced Sept. 12, ends Bayer's decades-long effort to win back its corporate name in the U.S. The German diversified pharmaceutical and chemical company was stripped of the Bayer trademark after World War I.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning